Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides Demonstrates Different Alloreactivity Potential In HLA-Matched and Mismatched Donor-Recipient Pairs
Badar Abdul Razzaq, Allison Scalora, Vishal Koparde, Jeremy Meier, Musa Mahmood, Salman Salman, Max Jameson-Lee, Myrna Serrano, Nihar Sheth, Mark Voelkner, David Kobulnicky, Catherine Roberts, Andrea Ferreira-Gonzalez, Masoud Manjili, Gregory Buck, Michael Neale, Amir Toor
Abstract
Abstract.Immune reconstitution kinetics and subsequent clinical outcomes in HLA matched recipients of allogeneic stem cell transplantation (SCT) are variable and difficult to predict. Considering SCT as a dynamical system, may allow sequence differences across the exomes of the transplant donors and recipients to be used to simulate an alloreactive T cell response, which may allow better clinical outcome prediction. To accomplish this, whole exome sequencing was performed on 34 HLA matched SCT donor-recipient pairs (DRP), and the nucleotide sequence differences translated to peptides. The binding affinity of the peptides to the relevant HLA in each DRP was determined. The resulting array of peptide-HLA binding affinity values in each patient was considered as an operator modifying a hypothetical T cell repertoire vector, in which each T cell clone proliferates in accordance to the logistic equation of growth. Using an iterating system of matrices, each simulated T cell clones growth was calculated with the steady state population being proportional to the magnitude of the binding affinity of the driving HLA-peptide complex. Incorporating competition between T cell clones responding to different HLA-peptide complexes reproduces a number of features of clinically observed T cell clonal repertoire in the simulated repertoire. These include, sigmoidal growth kinetics of individual T cell clones and overall repertoire, Power Law clonal frequency distribution, increase in repertoire complexity over time with increasing clonal diversity and finally, alteration of clonal dominance when a different antigen array is encountered, such as in stem cell transplantation. The simulated, alloreactive T cell repertoire was markedly different in HLA matched DRP. The patterns were differentiated by rate of growth, and steady state magnitude of the simulated T cell repertoire and demonstrate a possible correlation with survival. In conclusion, exome wide sequence differences in DRP may allow simulation of donor alloreactive T cell response to recipient antigens and may provide a quantitative basis for refining donor selection and titration of immunosuppression following SCT.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dynamical System Modeling to Simulate Donor T Cell Response to Whole Exome Sequencing-Derived Recipient Peptides: Understanding Randomness in Clinical Outcomes Following Stem Cell Transplantation
V Koparde, B Abdul Razzaq, … A. Toor·bioRxiv·Apr 6, 2017
- Determining the Quantitative Principles of T Cell Response to Antigenic Disparity: The Case of Stem Cell Transplant Donor-Recipient Exome Wide Mismatching and HLA Bound Alloreactive Peptides
Ali Salman, Vishal Koparde, … Amir Toor·bioRxiv·Apr 21, 2018
- Evolution of chronic lymphocytic leukemia after allogeneic stem cell transplant
Haven R. Garber, Danwei Wang, … Jeffrey J. Molldrem·bioRxiv·Jan 22, 2025
- The Influence of Lymphoid Reconstitution Kinetics on Clinical Outcomes in Allogeneic Stem Cell Transplantation
David J Kobulnicky, Roy T Sabo, … Amir A Toor·Leukemia & LymphomaPeer-reviewed·Apr 4, 2018
- Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients
J. R. Erickson, T. Stevens-Ayers, … M. Prlic·bioRxiv·Sep 14, 2021
- HLA-DQ monomer-based enrichment of alloreactive CD4 T cells
Zhuldyz Zhanzak, Davide Cina, … Christian P. Larsen·bioRxiv·May 30, 2025